home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Better Detection To Tackle Bioterrorism

 
  April, 26 2006 9:31
your information resource in human molecular genetics
 
     
Scientists have developed a test that is at least a thousand times more sensitive than the best current approaches for detecting in the field trace quantities of cholera and botulinum toxins, two possible agents for contamination of food or drinking water during a bioterror attack. The method, described in the May 2006 issue of Nature Biotechnology, provides results in just 3 hours.

Until now, the most rapid and sensitive approach to biotoxin detection has involved coupling a technique called PCR, perhaps best known for its capacity for massive amplification of trace amounts of DNA found at crime scenes, with the exquisite specificity conferred by antibodies capable of specifically fishing biotoxins out from complex samples such as milk.

To boost the sensitivity of this approach, Jeffrey Mason and colleagues package about sixty molecules that initiate PCR into a hollow oil droplet (called a liposome) decorated with receptors for the toxin. When present, the toxin binds the receptors, and when the liposome is subsequently broken open, the released PCR-initiating molecules amplify the signal and enable detection of vanishingly small amounts of biotoxins - even against a background of harmless components in urine and runoff water from land housing livestock.

Not only is the test exquisitely sensitive, but it also avoids the use of animals, unlike the US Centers for Disease Control botulinum bioassay.

Author contact:

Jeffrey T. Mason (Armed Forces Institute of Pathology, Rockville, MD, USA)
E-mail: mason@afip.osd.mil

Additional contact for comment on this paper:

Timothy J. O'Leary (Veterans Health Administration, Washington, DC, USA)
E-mail: timothy.oleary@va.gov

Abstract available online.

(C) Nature Biotechnology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.